Strategic Operations and Analysis: Realizing Integrated Planning and Gross-to-Net
June 23, 2026
BioProcess Theatre
Type: BioProcess Session
Whether emerging or mature, branded, specialty or generic, Life Sciences manufacturers that have enabled Integrated Planning and Gross-to-Net analytical capabilities are more successful in meeting their market access objectives and optimizing their operations. Join Argano’s Pharosity Consulting team as they discuss real-world examples, enablement approaches for manufacturers in different situations, and the light-bulb moments when the benefits are fully realized. The team will also discuss the tools available for manufacturers large and small, and how to begin or enhance your journey to implementation.
Speakers
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}